ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,118,911 | -73.4% | 279,222 | -3.7% | 0.00% | -83.3% |
| Q2 2023 | $11,730,591 | 0.0% | 290,074 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $11,730,591 | -14.3% | 290,074 | -1.4% | 0.01% | -14.3% |
| Q4 2022 | $13,684,417 | -99.0% | 294,162 | +982.7% | 0.01% | +600.0% |
| Q3 2022 | $1,409,256,000 | +9.7% | 27,169 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,284,279,000 | -3.3% | 27,169 | +45.6% | 0.00% | 0.0% |
| Q1 2022 | $1,328,148,000 | +29.8% | 18,659 | +36.4% | 0.00% | – |
| Q4 2021 | $1,022,991,000 | +46.0% | 13,680 | +10.9% | 0.00% | – |
| Q3 2021 | $700,525,000 | +29.1% | 12,331 | 0.0% | 0.00% | – |
| Q2 2021 | $542,687,000 | -18.7% | 12,331 | -8.9% | 0.00% | – |
| Q1 2021 | $667,645,000 | +139.2% | 13,537 | +104.2% | 0.00% | – |
| Q4 2020 | $279,123,000 | -45.1% | 6,630 | -40.4% | 0.00% | – |
| Q3 2020 | $508,846,000 | -25.8% | 11,115 | -18.6% | 0.00% | – |
| Q2 2020 | $685,568,000 | -10.0% | 13,654 | -7.8% | 0.00% | -100.0% |
| Q1 2020 | $761,936,000 | -5.2% | 14,815 | +13.9% | 0.00% | – |
| Q4 2019 | $803,387,000 | +15.1% | 13,004 | +11.9% | 0.00% | – |
| Q3 2019 | $698,070,000 | -36.4% | 11,619 | -10.7% | 0.00% | -100.0% |
| Q2 2019 | $1,097,279,000 | -5.8% | 13,004 | +6.7% | 0.00% | 0.0% |
| Q1 2019 | $1,164,293,000 | +88.5% | 12,189 | +39.8% | 0.00% | 0.0% |
| Q4 2018 | $617,638,000 | -17.2% | 8,720 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $745,810,000 | -40.5% | 8,727 | -19.3% | 0.00% | 0.0% |
| Q2 2018 | $1,253,458,000 | +114.6% | 10,815 | +49.8% | 0.00% | – |
| Q1 2018 | $584,170,000 | +142.8% | 7,220 | +76.1% | 0.00% | – |
| Q4 2017 | $240,588,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
| Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
| Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
| Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
| Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
| ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
| Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
| Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |